胰岛素泵概述胰岛素泵治疗的适应症与禁忌症胰岛素泵治疗规范

1985Cohen2003Hanaire-Broutin2000Home1982Hoogma2005Nathan1982Saurbrey1988Schmitz1989Weintrob2004CSII与多次注射(MI)的HbA1c差异(%)Subtotal(95%CI)平行研究DeVries2002Doyle2004Lepore2003Meschi1982Nosadini1988Nuboer2008Oslostudy1985to1992Pozzilli2003Skogsberg2008Tsui2001Subtotal(95%CI)Total(95%CI)-0.10[-0.43,0.23]0.40[-0.58,1.38]-0.42[-1.11,0.27]-0.35[-0.62,-0.08]-1.70[-3.50,0.10]-0.22[-0.38,-0.06]-2.48[-3.86,-1.10]0.00[-0.31,0.31]-0.70[-1.94,0.54]-0.20[-0.59,0.19]-0.25[-0.45,-0.05]-0.80[-1.65,0.05]-0.90[-1.68,-0.12]0.30[-0.53,1.13]0.20[-1.94,2.34]-0.80[-1.35,-0.25]-0.48[-0.90,-0.06]-0.40[-1.51,0.71]0.10[-0.31,0.51-0.20[-0.42,0.02]-0.25[-0.18,0.68]-0.26[-0.52,-0.00]-0.25[-0.40,-0.10]差值(95%CI)CSII更好MI更好-4-2024一项共纳入23项研究、976例T1DM患者的荟萃分析,对其中的20个研究进行了HbA1c的分析MissoML,etal.CochraneDatabaseSystRev.2010;(1):CD005103